Nature Communications (Feb 2019)

Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer

  • D. Merino,
  • T. S. Weber,
  • A. Serrano,
  • F. Vaillant,
  • K. Liu,
  • B. Pal,
  • L. Di Stefano,
  • J. Schreuder,
  • D. Lin,
  • Y. Chen,
  • M. L. Asselin-Labat,
  • T. N. Schumacher,
  • D. Cameron,
  • G. K. Smyth,
  • A. T. Papenfuss,
  • G. J. Lindeman,
  • J. E. Visvader,
  • S. H. Naik

DOI
https://doi.org/10.1038/s41467-019-08595-2
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 12

Abstract

Read online

Triple negative breast cancers (TNBC) disseminate and metastasise, but the clonal relationship of metastases to primary tumours is poorly understood. Here, the authors use cellular barcoding of TNBC patient-derived xenografts and track the fate of barcoded clones in primary tumours and their metastases, including after resection or chemotherapy.